These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30070712)

  • 1. Vascular Immunotargeting: Take the Highway to the First Exit.
    Muzykantov VR; Brenner JS
    Hepatology; 2018 Nov; 68(5):1672-1674. PubMed ID: 30070712
    [No Abstract]   [Full Text] [Related]  

  • 2. [The internalization of immunotargeting drugs for hepatocellar carcinoma and its significance].
    Sui Y; Sun Z; Chen Z
    Zhonghua Yi Xue Za Zhi; 1996 Nov; 76(11):845-7. PubMed ID: 9275537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotargeting in the diagnosis and treatment of liver cancer.
    Keegan-Rogers V; Wu GY
    Hepatology; 1989 Apr; 9(4):646-8. PubMed ID: 2925167
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell-selective intracellular delivery of a foreign enzyme to endothelium in vivo using vascular immunotargeting.
    Scherpereel A; Wiewrodt R; Christofidou-Solomidou M; Gervais R; Murciano JC; Albelda SM; Muzykantov VR
    FASEB J; 2001 Feb; 15(2):416-26. PubMed ID: 11156957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotargeting chemotherapy for AFP-producing pediatric liver cancer using the conjugates of anti-AFP antibody and anti-tumor agents.
    Hata Y; Takada N; Sasaki F; Abe T; Hamada H; Takahashi H; Uchino J; Tsukada Y
    J Pediatr Surg; 1992 Jun; 27(6):724-7. PubMed ID: 1380075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunotargeting of tumors: state of the art and prospects in 2000].
    Pèlegrin A; Xavier F; Barbet J; Bartholeyns J; Baty D; Buchegger F; Chatal JF; Dufief F; Gurreau D; Gruaz-Guyon A; Lamotte D; Leserman L; Mach JP; Robert B; Saccavini JC; Teillaud JL; Teulon I
    Bull Cancer; 2000 Nov; 87(11):777-91. PubMed ID: 11125287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on immunohistochemical localization and immunotargeting of monoclonal antibody against human hepatocellular carcinoma].
    Ji YY
    Zhonghua Zhong Liu Za Zhi; 1993 Sep; 15(5):335-8. PubMed ID: 8174475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotargeting of catalase to the pulmonary endothelium alleviates oxidative stress and reduces acute lung transplantation injury.
    Kozower BD; Christofidou-Solomidou M; Sweitzer TD; Muro S; Buerk DG; Solomides CC; Albelda SM; Patterson GA; Muzykantov VR
    Nat Biotechnol; 2003 Apr; 21(4):392-8. PubMed ID: 12652312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunotargeting approach to adjuvant-independent subunit vaccine design.
    Barber BH
    Semin Immunol; 1997 Oct; 9(5):293-301. PubMed ID: 9327524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotargeting of the pulmonary endothelium via angiotensin-converting-enzyme in isolated ventilated and perfused human lung.
    Nowak K; Kölbel HC; Metzger RP; Hanusch C; Frohnmeyer M; Hohenberger P; Danilov SM
    Adv Exp Med Biol; 2013; 756():203-12. PubMed ID: 22836637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radio-immunotargeting in colorectal carcinoma.
    Rutgers EJ
    Eur J Cancer; 1995; 31A(7-8):1243-7. PubMed ID: 7577031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radio-immunotargeting in experimental animal models of intraperitoneal cancer.
    Fjeld JG; Vergote I; De Vos L; Nustad K
    Acta Obstet Gynecol Scand Suppl; 1992; 155():105-11. PubMed ID: 1502887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo expression of two novel tumor-associated antigens and their use in immunolocalization of human hepatocellular carcinoma.
    Takahashi H; Ozturk M; Wilson B; Maki A; Ozawa K; Koizumi M; Endo K; Strauss W; Shouval D; Wands J
    Hepatology; 1989 Apr; 9(4):625-34. PubMed ID: 2538386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of the adjuvant-independent antibody response to immunotargeting. Target structure dependence, isotype distribution, and induction of long term memory.
    Skea DL; Barber BH
    J Immunol; 1993 Oct; 151(7):3557-68. PubMed ID: 8376792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor immunotargeting using innovative radionuclides.
    Kraeber-Bodéré F; Rousseau C; Bodet-Milin C; Mathieu C; Guérard F; Frampas E; Carlier T; Chouin N; Haddad F; Chatal JF; Faivre-Chauvet A; Chérel M; Barbet J
    Int J Mol Sci; 2015 Feb; 16(2):3932-54. PubMed ID: 25679452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanobody; an old concept and new vehicle for immunotargeting.
    Rahbarizadeh F; Ahmadvand D; Sharifzadeh Z
    Immunol Invest; 2011; 40(3):299-338. PubMed ID: 21244216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycan bioengineering in immunogen design for tumor T antigen immunotargeting.
    Sendra VG; Zlocowski N; Ditamo Y; Copioli S; Tarp MP; Bennett EP; Clausen H; Roth GA; Nores GA; Irazoqui FJ
    Mol Immunol; 2009 Oct; 46(16):3445-53. PubMed ID: 19726087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatoblastoma: actual therapeutic strategies. A case report.
    Van Bastelaere S; Quisthoudt P; Coene L; Jutten G; Vanderputte S; Cerckel L
    Acta Chir Belg; 1995; 95(2):92-4. PubMed ID: 7754739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunotargeting approach to adjuvant-independent immunization with influenza haemagglutinin.
    Skea DL; Douglas AR; Skehel JJ; Barber BH
    Vaccine; 1993; 11(10):994-1002. PubMed ID: 8212832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening phage display libraries for organ-specific vascular immunotargeting in vivo.
    Valadon P; Garnett JD; Testa JE; Bauerle M; Oh P; Schnitzer JE
    Proc Natl Acad Sci U S A; 2006 Jan; 103(2):407-12. PubMed ID: 16384919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.